Misconceptions and Facts About Hypertrophic Cardiomyopathy

Am J Med. 2016 Feb;129(2):148-52. doi: 10.1016/j.amjmed.2015.07.035. Epub 2015 Aug 20.

Abstract

Hypertrophic cardiomyopathy is the most common genetic heart disease. Once considered relentless, untreatable, and deadly, it has become a highly treatable disease with contemporary management. Hypertrophic cardiomyopathy is one of cardiology's "great masqueraders." Mistakes and delays in diagnosis abound. Hypertrophic cardiomyopathy commonly "masquerades" as asthma, anxiety, mitral prolapse, and coronary artery disease. However, once properly diagnosed, patients with hypertrophic cardiomyopathy can be effectively managed to improve both symptoms and survival. This review highlights some of the misconceptions about hypertrophic cardiomyopathy. Providers at all levels should have awareness of hypertrophic cardiomyopathy to promptly diagnose and properly manage these individuals.

Keywords: Echocardiography; Hypertrophic cardiomyopathy; Septal reduction therapy.

Publication types

  • Review

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Cardiomyopathy, Hypertrophic* / complications
  • Cardiomyopathy, Hypertrophic* / diagnosis
  • Cardiomyopathy, Hypertrophic* / epidemiology
  • Cardiomyopathy, Hypertrophic* / genetics
  • Cardiomyopathy, Hypertrophic* / therapy
  • Death, Sudden, Cardiac / etiology
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy
  • United States / epidemiology

Substances

  • Antihypertensive Agents